TSPAN8 and breast carcinoma: Addressing the question of the selective advantages mediated by TSPAN8 in breast cancer, we observed that Tspan8+ cells exhibit significantly greater radiation resistance compared with control Tspan8− mesenchymal‐like cells, suggesting that MET may also be linked to radiation resistance.